- Hem
- Om universitetet
- Hitta person
- Kevin Ali
Kevin Ali
Doktorand
Avd för kirurgiAnknuten till forskning
Avd för kirurgi-
Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new
inhibitors
Donika Klenja-Skudrinja, Kevin Ali, David Walker, Maureen Higgins, Angana Patel, Dorota Raj, Anna Creelman, Charlotte Mcdowall, Conor Taylor, Tomasz Wenta, Erik Larsson, Clotilde Wiel, Volkan Sayin, Laureano de la Vega
REDOX BIOLOGY - 2025 -
Novel insights into the BACH1-NRF2 axis; new target genes and
inhibitors
Donika Klenja-Skudrinja, Kevin X. Ali, Volkan I. Sayin, Laureano de la Vega
FREE RADICAL BIOLOGY AND MEDICINE - 2025 -
Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain
metastasis
Sama I Sayin, Ella M. Eklund, Kevin X. Ali, Jozefina J. Dzanan, Moe Xylander, Martin Dankis, Per Lindahl, Volkan I. Sayin, Andreas Hallqvist, Clotilde Wiel
FRONTIERS IN ONCOLOGY - 2025 -
Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against
BACH1
R. Moreno, L. Casares, M. Higgins, Kevin X. Ali, T. Honda, Clotilde Wiel, Volkan I. Sayin, A. T. Dinkova-Kostova, L. de la Vega
Free Radical Biology and Medicine - 2022 -
The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its
activity
L. Casares, R. Moreno, Kevin X. Ali, M. Higgins, S. D. Naidu, G. Neill, L. Cassin, A. E. Kiib, E. B. Svenningsen, A. Minassi, T. Honda, T. B. Poulsen, Clotilde Wiel, Volkan I. Sayin, A. T. Dinkova-Kostova, D. Olagnier, L. de la Vega
Redox Biology - 2022